Pathogen Discovery in the Post-COVID Era

Cheng Guo1, Jian-Yong Wu2

  • 1Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.

PubMed

Insights

The COVID-19 pandemic accelerated pathogen discovery innovations. New technologies and global collaboration now enable faster identification of infectious agents from diverse samples.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Public Health
  • Pathogen Discovery

Background:

  • The COVID-19 pandemic underscored the critical need for rapid pathogen identification.
  • Effective outbreak management and prevention rely on early and accurate detection of novel infectious agents.

Purpose of the Study:

  • To review recent innovations and paradigm shifts in pathogen discovery.
  • To summarize advancements in technology, applications, and causation-proving strategies.
  • To explore trends in pathogen discovery from clinical and environmental samples.

Main Methods:

  • Review of recent literature and technological advancements in pathogen discovery.
  • Analysis of strategies for identifying pathogens in acute and historical infections.
  • Exploration of approaches for sample analysis and global network establishment.

Main Results:

  • Accelerated progress in pathogen discovery technologies post-COVID-19.
  • Enhanced capabilities for rapid and accurate identification of diverse pathogens.
  • Increased emphasis on collaborative global networks for infectious disease surveillance.

Conclusions:

  • The post-COVID era signifies a transformative period for pathogen discovery.
  • Technological innovation and international collaboration are key to future infectious disease preparedness.
  • Effective pathogen discovery from various sample types is crucial for public health.